Healthcare

Share

Facebook Twitter Linkedin

Shield Therapeutics plc (LSE:STX)

2.436 GBX

+0.036 1.500%

Last Updated at: 2025-05-12T07:11:00Z

Risk Disclaimer STX chart by TradingView

Back to LSE:STX

Risk Disclaimer STX chart by TradingView

Previous Close (in GBX)	2.4
Change	+0.036 1.500%
52 W H/L (in GBX)	12.850/5.720
EBITDA (in GBX)	-28.276M
PE Ratio	--
Volume	178628
Diluted Eps TTM	-0.12

Total Assets (in GBX)	22.074M
Total Liabilities (in GBX)	16.647M
Revenue TTM (in GBX)	7.397M
Cash (in GBX)	2.821M
Market Cap (in GBX)	50.443 M
Revenue Per Share TTM	0.016
Gross Profit TTM (in GBX)	1.997M

Summary

---

Income Statement

Balance Sheet

Change in Cash

Operating Cash

Shield Therapeutics plc

Shield Therapeutics plc, a specialty pharmaceutical company, focuses on commercialization of pharmaceuticals to treat unmet medical needs. Its lead product is Accrufer/Feraccru, a non-salt based oral therapy for adults to treat the iron deficiency with or without anemia. Shield Therapeutics plc was founded in 2008 and is based in Gateshead, the United Kingdom.

Northern Design Centre, Gateshead, United Kingdom, NE8 3DF

44 1915 118 500

https://www.shieldtherapeutics.com

Employees: 27

Key Executives

Sr. No.	Name	Title	Year Born
1.	Mr. Gregory P. Madison	CEO & Exec. Director	1968
2.	Dr. Christian Schweiger M.D., Ph.D.	Co-Founder & Non Exec. Director	1967
3.	Mr. Hans-Peter Rudolf	Chief Financial Officer	NA
4.	Ms. Lucy Huntington-Bailey	Gen. Counsel & Company Sec.	NA
5.	Ms. Suzanne Wood	Group HR Director	NA
6.	Ms. Carol Akinola	Head of Pharmacovigilance & Medical Information	NA
7.	Dr. José A. Menoyo M.D.	Chief Medical Officer	NA

Peers

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Company	Change (GBX)	Price (GBX)	Trailing PE(x)	Forward PE(x)	Price Sales TTM(x)	Price to Book Value(x)	Enterprise Value to Revenue(x)	Enterprise Value to EBITDA(x)
HLN Haleon PLC	0.000 0.000%	405.1	24.730	16.863	2.631	1.808	3.173	16.574
HIK Hikma Pharmaceuticals PLC	-62.416 3.115%	2018	33.450	11.136	1.448	2.323	1.756	8.979
HCM HUTCHMED China Ltd	-16.992 7.453%	217	0.000	0.000	3.218	3.974	2.392	-19.425
INDV Indivior PLC	-5.500 0.664%	845.5	0.000	0.000	1.597	48.691	1.170	-4.762

• Income Statement
• Balance Sheet
• Cash Flow

Income Statement

(Currency in GBX)

Breakdown	31-12-2022	31-12-2021	31-12-2020	31-12-2019	31-12-2018
Income Before Tax	-40.082M	-19.565M	-1.886M	-9.066M	-5.153M
Minority Interest	-	-	-	-	-
Net Income	-40.444M	-19.336M	-2.63M	-8.8M	-1.794M
Selling General Administrative	27.331M	20.023M	5.622M	4.093M	6.589M
Gross Profit	1.997M	0.539M	9.033M	0.234M	11.57M
Reconciled Depreciation	2.362M	2.207M	2.705M	2.621M	2.354M
Ebit	-25.706M	-19.952M	-1.886M	-9.035M	-5.118M
Ebitda	-22.623M	-17.35M	0.819M	-6.396M	-2.764M
Depreciation And Amortization	3.083M	2.602M	2.705M	2.639M	2.354M
Operating Income	-25.706M	-19.952M	-1.886M	-9.035M	-5.168M
Other Operating Expenses	30.173M	21.471M	12.541M	9.754M	17.049M
Interest Expense	0.389M	0.008M	0M	0.049M	0.035M
Tax Provision	0.362M	-0.229M	0.744M	-0.266M	-3.359M
Interest Income	0.721M	0.395M	0.003M	0.018M	0.02M
Net Interest Income	0.332M	0.387M	0.002M	0.016M	-0.015M
Income Tax Expense	0.362M	-0.229M	0.744M	-0.266M	-3.359M
Total Revenue	4.467M	1.519M	10.387M	0.719M	11.881M
Total Operating Expenses	27.703M	20.491M	11.187M	9.269M	16.738M
Cost Of Revenue	2.47M	0.98M	1.354M	0.485M	0.311M
Total Other Income Expense Net	-14.376M	0.387M	0.268M	-0.031M	0.015M
Net Income From Continuing Ops	-40.444M	-19.336M	-2.63M	-8.8M	-1.794M
Net Income Applicable To Common Shares	-40.444M	-19.336M	-2.63M	-8.8M	-1.792M

Balance Sheet

(Currency in GBX)

Breakdown	31-12-2022	31-12-2021	31-12-2020	31-12-2019	31-12-2018
Total Assets	22.074M	44.413M	32.528M	36.319M	43.381M
Intangible Assets	11.783M	26.851M	27.266M	29.898M	30.957M
Other Current Assets	-	3.506M	0.911M	1.306M	2.531M
Total Liab	16.647M	3.38M	2.252M	4.174M	2.951M
Total Stockholder Equity	5.427M	41.033M	30.276M	32.145M	40.43M
Other Current Liab	1.061M	0.11M	0.753M	0.607M	0.403M
Common Stock	3.891M	3.238M	1.764M	1.758M	1.746M
Capital Stock	3.891M	3.238M	1.764M	1.758M	1.746M
Retained Earnings	-146.638M	-106.595M	-88.251M	-86.392M	-78.048M
Good Will	-	-	-	-	-
Other Assets	-	9.529M	8.434M	8.961M	7.942M
Cash	2.821M	12.117M	2.94M	4.141M	9.776M
Cash And Equivalents	-	-	-	-	-
Total Current Liabilities	10.639M	3.38M	2.252M	4.174M	2.951M
Current Deferred Revenue	-	-	-	-	-
Net Debt	3.276M	-11.961M	-2.912M	-4.121M	-9.776M
Short Term Debt	0.089M	0.156M	0.028M	0.02M	-
Short Long Term Debt	-	-	-	-	-
Short Long Term Debt Total	6.097M	0.156M	0.028M	0.02M	-
Other Stockholder Equity	148.174M	144.39M	116.763M	116.779M	116.753M
Property Plant Equipment	0.197M	0.304M	0.032M	0.026M	0.155M
Total Current Assets	10.094M	17.258M	5.23M	6.395M	12.416M
Long Term Investments	-	-	-	-	-
Short Term Investments	-	-	-	-	-
Net Receivables	5.38M	1.773M	0.656M	1.147M	1.962M
Long Term Debt	6.008M	-	-	-	-
Inventory	1.457M	1.635M	1.379M	0.948M	0.109M
Accounts Payable	9.489M	3.114M	1.471M	3.547M	2.548M
Accumulated Other Comprehensive Income	-	-	-	-0.052M	-0.021M
Non Currrent Assets Other	-	26.851M	-	29.924M	30.965M
Non Current Assets Total	11.98M	27.155M	27.298M	29.924M	30.965M
Capital Lease Obligations	0.089M	0.156M	0.028M	0.02M	-
Long Term Debt Total	-	-	-	-	-

Cash Flow

(Currency in GBX)

Breakdown	31-12-2022	31-12-2021	31-12-2020	31-12-2019	31-12-2018
Investments	-1.695M	-2.051M	-0.02M	-1.366M	-3.345M
Total Cashflows From Investing Activities	-1.695M	-2.051M	-0.02M	-1.366M	-3.295M
Total Cash From Financing Activities	7.707M	27.584M	-0.047M	-0.203M	-0.379M
Net Income	-40.444M	-19.336M	-2.63M	-8.8M	-1.794M
Change In Cash	-9.296M	9.177M	-1.201M	-5.635M	-3.523M
Begin Period Cash Flow	12.117M	2.94M	4.141M	9.776M	13.299M
End Period Cash Flow	2.821M	12.117M	2.94M	4.141M	9.776M
Total Cash From Operating Activities	-18.247M	-16.738M	-1.4M	-4.066M	-0.178M
Depreciation	2.362M	2.207M	2.705M	2.621M	2.354M
Other Cashflows From Investing Activities	0.2M	0.013M	0.003M	0.018M	0.05M
Dividends Paid	-	-	-	-	-
Change To Inventory	0.178M	-0.256M	-0.431M	-0.839M	0.016M
Sale Purchase Of Stock	-0.082M	-	-	-	-
Other Cashflows From Financing Activities	7.702M	-0.121M	-0.053M	-0.229M	-3.345M
Capital Expenditures	1.895M	2.064M	0.023M	1.384M	3.345M
Change In Working Capital	4.708M	-2.007M	-2.622M	0.553M	-0.255M
Other Non Cash Items	14.384M	-0.353M	-0.268M	0.031M	-0.015M
Free Cash Flow	-20.142M	-18.802M	-1.423M	-5.45M	-3.523M

No data found

Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peertrades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).

• Top Gainer
• Top Loser